|
|
||||||||
1 Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115; and 2 Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110
| |
ABSTRACT |
|---|
|
|
|---|
Overexpression of a truncated Kv1.1 channel transgene in the heart (Kv1DN) resulted in mice with a prolonged action potential duration due to marked attenuation of a rapidly activating, slowly inactivating potassium current (IK,slow1) in ventricular myocytes. Optical mapping and programmed electrical stimulation revealed inducible ventricular tachycardia due to spatial dispersion of repolarization and refractoriness. Here we show that a delayed rectifier with slower inactivation kinetics (IK,slow2) was selectively upregulated in Kv1DN cardiocytes. This electrical remodeling was spatially restricted to myocytes derived from the apex of the left ventricle. Biophysical and pharmacological studies of IK,slow2 indicate that it resembles Kv2-encoded currents. Northern blot analyses and real-time PCR revealed upregulation of Kv2.1 transcript in Kv1DN mice. Crossbreeding of Kv1DN mice with mice expressing a truncated Kv2.1 polypeptide (Kv2DN) eliminated IK,slow2. In summary, our data indicate that the spatially restrictive upregulation of Kv2.1-encoded currents underlies the increased dispersion of the repolarization observed in Kv1DN mice.
cardiac arrhythmia; electrophysiology; potassium channels; long QT syndrome
| |
INTRODUCTION |
|---|
|
|
|---|
MUTATIONS IN GENES coding for potassium and sodium channels that cause a prolongation of the QT interval, which may lead to fatal ventricular arrhythmias, were recently identified (15). Abnormalities in ion channel expression were also reported in congestive heart failure and atrial fibrillation (6). These abnormalities can cause marked spatial and temporal dispersion of repolarization and may lead to sustained reentrant arrhythmias that can then deteriorate to ventricular fibrillation (2).
Recent advances in mice genetically modified at various potassium channels have fostered a better understanding of the electrophysiological roles of ionic currents in this species. Functional knockout of the rapidly activating (IKr) or slowly activating (IKs) components of the delayed rectifier potassium current, the two important repolarization currents responsible for the congenital long QT syndrome, did not lead to either QT prolongation or arrhythmogenic substrate (3, 13). In contrast, attenuation of Kv1.5-, Kv4-, or Kv2-encoded currents in mice with a dominant-negative (DN) approach resulted in prolongation of the action potential duration (APD) in vitro and the QT interval of the electrocardiogram in vivo (5, 14, 16). These results confirmed the substantial difference in ventricular ion channel expression in adult mice from that in humans. Previous studies examined the electrophysiological properties of Kv1.5- and Kv4-like currents in ventricular myocytes isolated from the adult mouse heart, which demonstrated two distinct outward potassium currents, i.e., a rapidly activating, slowly inactivating current (IK,slow1) and a fast component transient outward current (Ito,f) (5, 10, 18). However, the properties of the Kv2-like current have not been illustrated.
The transgenic mouse model (Kv1DN) of long QT syndrome was created by overexpression of the NH2 terminus and the first transmembrane segment of Kv1.1 in the heart (Kv1.1N206Tag) (14). This truncated channel forms homo- and heteromultimeric complexes in vitro and coassembles with wild-type Kv1.x channels to form nonfunctional complexes that are trapped in the endoplasmic reticulum (9). Mice overexpressing Kv1.1N206Tag in the heart are characterized by a prolonged QT interval and a spontaneous monomorphic ventricular tachycardia (VT) (14). Transvenous programmed electrical stimulation induced polymorphic VT in 50% of these mice (12). Cardiac myocytes derived from these mice had a prolonged APD caused by the loss of a rapidly activating, slowly inactivating current, IK,slow1, which correlated with a marked decrease in the level of Kv1.5 polypeptide (14, 18). Programmed electrical stimulation at the apex, but not at the base, of Kv1DN hearts perfused on a Langendorff system resulted in a long-lasting VT (4). Optical mapping experiments revealed substantially longer effective refractory periods (ERPs) at the base of Kv1DN left ventricles, which resulted in increased spatial dispersion of repolarization and reentrant arrhythmia (4). Interestingly, none of the other mouse models, in which the IKr (3), IKs (13), Kv4 (5), or Kv2 (16) channel was functionally knocked out, was reported to have proarrhythmic activity. Therefore, uncovering the ionic basis of these discrepancies may be very helpful for a better understanding of how these channels are functionally integrated to maintain the electrical stability of the heart.
In the present study, we characterize an electrical remodeling response of the cardiocytes derived from the Kv1DN mouse hearts. A current component (IK,slow2) is selectively upregulated in the myocytes isolated from the apex of the left ventricle but not in those from the base. This spatially restricted electrical remodeling may underlie the enhanced dispersion of repolarization observed in Kv1DN hearts and the spontaneous and inducible arrhythmias in these animals. The upregulation of Kv2.1 transcripts in Kv1DN mouse hearts revealed by Northern blot and RT-PCR and the elimination of IK,slow2 in cardiocytes by crossbreeding of Kv1DN with Kv2DN mice suggest that Kv2.1 underlies the inducible component, IK,slow2.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Isolation of adult mouse ventricular myocytes. Mouse ventricular myocytes were obtained as described previously (14, 18). Briefly, control and Kv1DN adult FVB mouse (3-6 mo) hearts were perfused retrogradely with a Langendorff apparatus. A 5-min perfusion with oxygenated, nominally calcium-free solution A was followed by an 8- to 12-min perfusion with solution B. The ventricles were then chopped into small pieces, incubated at 37°C in solution B supplemented with 0.02 mg/ml protease (type XXIV; Sigma) for 5-10 min, and mechanically dispersed. Myocytes were obtained by repeated washing with a series of centrifugations at 500 rpm for 2-3 min and resuspension in 0.25, 0.5, and 1 mM calcium-containing solution A supplemented with 2% FCS. Calcium-tolerant, rod-shaped ventricular myocytes with clear striations were selected randomly for electrophysiological studies at room temperature. For the regional ion channel expression experiments, the apical and basal segments of the left ventricle free wall were obtained by cutting the left ventricle free wall, after removing the septum, horizontally into three parts and discarding the middle segment. We then proceeded as described above.
Electrophysiological study.
A whole cell patch-clamp technique (11) was used to
investigate changes in the ionic currents and action potentials of the myocytes isolated from control and Kv1DN mouse ventricles. In brief,
myocytes were superfused with Tyrode solution at 1-2 ml/min, and
the electrophysiological data were obtained with electrodes having a
resistance of 0.5-2 M
when filled with a standard pipette solution. The electrode was connected to an Axopatch 200A amplifier (Axon Instruments), and the signals were digitized through a DigiData 1200 interface and stored in the computer. pCLAMP 6.0.4 software (Axon
Instruments) was used to generate command pulses and acquire data.
After the membrane was ruptured, the cell capacitance was evaluated
(18). In this study, cell capacitances in the control and
Kv1DN myocytes were 160.4 ± 68 pF (n = 34) and
172.4 ± 48.1 pF (n = 39), respectively
(P > 0.05). To obtain correct voltage clamp and
minimize the voltage error that might result from the series
resistance, a technical adjustment similar to that in a previous study
(18) was made. Recordings were started after 5 min of
membrane rupture at room temperature (22-24°C). Linear "leakage" currents were corrected off-line only when the input resistances were
1 (but
0.3) G
(n = 5). Junction
potentials (~10 mV) resulting from the low-chloride pipette solution
were corrected off-line.
Solutions.
Solution A contained (in mM) 137 NaCl, 4.7 KCl, 1.2 MgCl2, 1.0 KH2PO4, 11 glucose, 10 HEPES, and 0.125 Na2EDTA, pH 7.35. Solution B
was made from solution A with 0.5 mg/ml collagenase (type I; Worthington), 0.2 mg/ml hyaluronidase (type II; Sigma), and 1% FCS
added. Tyrode solution contained (in mM) 137 NaCl, 5.4 KCl, 1.2 MgCl2, 1 CaCl2, 10 glucose, and 10 HEPES, pH
7.35 with NaOH. CoCl2 was added (2 mM) when potassium
currents were being recorded. For the pharmacological experiment
involving tetraethylammonium (TEA), extracellular KCl was substituted
with equimolar TEA · Cl when the concentration of
TEA was
2.5 mM to maintain a constant ionic strength. Other blocking
reagents were added directly into Tyrode solution. Standard pipette
solution was composed of (in mM) 110 K-aspartate, 20 KCl, 1 MgCl2, 0.5 CaCl2, 10 HEPES, 5 EGTA, 5 Mg2ATP, 5 Na-creatine phosphate, and 0.5 GTP-Tris, pH 7.2 with KOH (pCa 7.6). For calcium current
(ICa) recording, potassium in both the
Tyrode and pipette solutions was substituted with equimolar cesium.
Data analysis.
Electrophysiological data were analyzed with Clampfit 6.0, Microsoft Excel, and Microcal Origin 5.0. The current inactivation kinetics was described by a sum of exponentials with the following function: y(t) =
Ai · exp(
t/
i) + C, where Ai and
i represent the
amplitude(s) and time constant(s), respectively, for the inactivating current component(s), and C is the offset, which includes the remaining
portion of those components, other noninactivating currents, and the
leakage current. Goodness of fit was judged by visual inspection and the correlation coefficients (R), which were
normally
0.975 in this study. The number of exponentials was
determined by F-test (18), and
P < 0.05 was taken to indicate a better fit.
Concentration effects were quantified by fitting the data with a Hill
equation:
Idrug/Icontrol = 1/[1 + (D/IC50)nH], where D is
the drug concentration, IC50 is the concentration for 50%
inhibition, and nH is the Hill coefficient. Data
are expressed as means ± SD unless indicated. ANOVA was applied
for analyzing the multigroup data. Student's t-test was
used to compare unpaired data between two groups, and a two-tailed
P < 0.05 was taken to indicate statistical significance.
Generation of Kv1/Kv2DN mice. Adult female FVB mice heterozygous for the DN transgene Kv1.1N206 were crossbred with male C57/BL6 mice carrying the DN transgene Kv2.1N216 (16). The resulting animals were screened for the presence of one or two transgenes by PCR analyses of tail DNA. Kv1/Kv2DN mice expressed both transgenes.
| |
RESULTS |
|---|
|
|
|---|
IK,slow2 exists in both control and Kv1DN mouse
ventricular myocytes.
We previously reported (18) that the outward current of
adult mouse ventricular myocytes was composed of at least three components, each of which displayed distinct inactivation kinetics at
37°C. Here we confirm that, at room temperature, the decay of the
outward currents elicited in control myocytes by 5-s pulses could be
best fitted by three exponentials with the following time constants:
1
40 ms,
2
350 ms, and
3 = 1.6-2.0 s (Fig. 1, A and
C). These components represent
Ito, IK,slow1
(18), and IK,slow2,
respectively. By contrast, the outward currents in almost all the
myocytes (86 of 89 cells in this study) derived from Kv1DN mouse hearts
had only two exponential components (Fig. 1, B and
C). The time constants were indistinguishable from those of
Ito and IK,slow2
in the control myocytes, confirming that
IK,slow1 was completely eliminated. Only at
20 mV did the time constants of the fastest components
(Ito) differ between the two groups. However, it is unlikely that Ito inactivates
any faster at this particular membrane potential in the Kv1DN myocytes
than in control myocytes. In fact, Ito
occupies a relatively small segment (~200 ms) during the whole
recording course (5 s) because of its fast inactivation kinetics, and
its amplitude was relatively small at
20 mV, making clear separation
of this current from the overlapping IK,slow1 in control myocytes somewhat
difficult. In Fig. 1D, the relative amplitudes obtained from
the exponential fittings showed a larger proportion of
Ito in the total outward current in Kv1DN myocytes than in that of the controls (e.g., 53.4 ± 14.3% vs. 27.1 ± 8.2% at 20 mV; P < 0.01). However, the
absolute values of the amplitudes of Ito,
after normalization to individual cell capacitances, did not
significantly differ between the two groups (e.g., 16.4 ± 9.4 vs.
11.6 ± 5.6 pA/pF at 20 mV; P > 0.05).
|
TEA-sensitive IK,slow2 is upregulated in Kv1DN
myocytes.
Although the exponential fitting permits the assessment of the
amplitude values of each component, the accuracy of this method is
limited. We therefore applied TEA to better evaluate
IK,slow2. Our results showed that 5 mM TEA
inhibited most of the IK,slow2 without
significantly affecting the other two components (Fig. 2A). The time constants of the
inactivation kinetics (obtained by single-exponential fittings to the
current decays) of the TEA-sensitive current were indistinguishable
from those of IK,slow2 before the administration of TEA (data not shown). The TEA-sensitive current started to activate at about
30 mV, and the activation process was
relatively slow. The current-voltage relationship (Fig. 2B) showed an outward rectification. Interestingly, the current density of
the TEA-sensitive component in the Kv1DN myocytes was increased by
~90% at potentials positive to 30 mV compared with the control myocytes (P < 0.05). Thus cardiocytes derived from
Kv1DN hearts underwent electrical remodeling with a significant
enhancement of the expression of a TEA-sensitive current,
IK,slow2, to compensate for the loss of
IK,slow1.
|
40 mV
in Kv1DN myocytes also displayed densities at all test potentials
(ranging from
110 to
20 mV) indistinguishable from those of the
controls (data not shown). Similarly, the current density, activation
and inactivation kinetics and their voltage dependence, and the
recovery kinetics of the inward calcium current
(ICa,L) did not differ significantly between
the two groups (data not shown). These results indicate that the
electrical remodeling of the cardiocytes lacking
IK,slow1 is not a general, but rather a
targeted, response designed to compensate for the loss of
IK,slow1.
Regional remodeling: enhancement of IK,slow2 at apex of
Kv1DN hearts.
A number of studies have emphasized the electrical heterogeneity that
exists within the heart, pointing to regional differences both in
electrical properties of ventricular myocardium and in the response of
distinct regions to pharmacological agents and pathological states
(2). The current density of
IK,slow2 in randomly studied Kv1DN myocytes
(Fig. 2) displayed marked variation, suggesting varying densities of
this current in the Kv1DN mouse cardiocytes. Moreover, previous optical
mapping studies revealed markedly longer refractory periods at the base
than at the apex of Kv1DN hearts (4). A premature impulse
applied to the apex of Kv1DN hearts induced reentry after encountering
a functional line of conduction block (4). To further
evaluate the molecular basis of the spatial dispersion of the
repolarization, we compared the three major outward current components
expressed in the myocytes isolated from the apical segments of the left
ventricle free wall with those from the base segments of either control
or Kv1DN mouse hearts. Here, IK,slow1 and
IK,slow2 were determined by measuring the 25 µM 4-aminopyridine (4-AP)-sensitive (14) and 500 µM
TEA-sensitive currents, respectively, in response to a 5-s pulse from
HP of
80 mV to 40 mV. Ito was determined
by fitting the current traces in the presence of 25 µM 4-AP by two
exponentials. The current was elicited by a 1-s pulse from
80 to 40 mV. These studies revealed that cardiac myocytes derived from the apex
of Kv1DN hearts expressed a twofold higher density of
IK,slow2 current compared with cardiocytes derived from the base (P < 0.05; Fig.
3C). By contrast,
Ito density did not differ in cardiocytes
derived from either the apex or base. Moreover, in control myocytes, no
significant difference was found between the current densities of
Ito, IK,slow1, or
IK,slow2 expressed in cardiocytes derived
from the apex and those from the base. However, the current density of
IK,slow2 in the Kv1DN apical cells was
significantly greater than that in the control apical myocytes
(P < 0.01), whereas in the basal myocytes it remained similar to the level of IK,slow2 in the
control basal cells (P > 0.05). Together, these data
indicate a selective upregulation of
IK,slow2 in the apical segments of Kv1DN
hearts.
|
Biophysical properties of IK,slow2.
Because the TEA-sensitive current provided us with a fairly pure
IK,slow2, a single-exponential fit to the
rising phases of the current was performed to determine the activation
kinetics of IK,slow2. The resulting time
constants were then plotted as a function of the membrane potential.
These data showed no significant differences in activation time
constants between the control and Kv1DN groups (Fig.
4A), indicating that the
activation kinetics of IK,slow2 was not
altered in the transgenic mouse myocytes. The activation rate of
IK,slow2 was much slower than that of the other two major components of the outward current,
Ito and IK,slow1, which were described previously (18).
|
act) of
IK,slow2 are voltage dependent (Fig.
4A). When the test potentials (Vm)
were increased, the activation process was faster. This relationship is
well described by a single-exponential function:
act = A · exp(
Vm/k) +
0, where k defines the steepness of the
voltage dependence and
0 reflects the "steady-state"
time constants, which are normally obtained at the most positive
membrane potential. In the control group, the fitting yielded a
k of 2.47 ± 0.78 mV (A = 0.08 ± 0.18 ms and
0 = 18.86 ± 2.64 ms), whereas in
the Kv1DN group, the values of the three parameters were
k = 2.44 ± 0.66 mV, A = 0.03 ± 0.04 ms, and
0 = 21.95 ± 6.76 ms. No
statistically significant differences were found between these two groups.
The elimination of the contaminating
IK,slow1 in the Kv1DN myocytes enabled us to
better describe the electrophysiological properties of
IK,slow2. In fact, we did not observe any
significant difference in the biophysical and pharmacological
properties of IK,slow2 between control and
Kv1DN groups, thus validating the approach of further characterizing
this current in the Kv1DN mouse cardiocytes. We next determined the
steady-state activation of IK,slow2. A
prepulse of 200 ms from the holding potential (HP) of
50 mV to 50 mV
was applied 3 ms before the test steps to inactivate Ito. The 100-ms test pulses ranging from
50 to 40 mV were followed by a repolarization step of 100 ms at
40
mV to evoke the tail currents (Fig. 4B, inset).
The tail currents were measured as the difference between the peak
current and that at the end of the pulse, normalized to the maximal
current (I/Imax), and plotted as
a function of the membrane potentials (Fig. 4B). The
steady-state activation is well described by the Boltzmann function:
I/Imax = 1/{1 + exp[(V1/2
Vm)/S]}, where
Vm is the membrane potential, V1/2 is the half-maximal activation voltage, and
S is the slope factor that reflects the steepness of the
voltage dependence. The resulting V1/2 and
S from seven observations were
13.5 ± 5.8 and
7.9 ± 2.1 mV, respectively.
As described above, IK,slow2 inactivated
very slowly, with a time constant of ~1.6 s at room temperature. The
inactivation kinetics, similar to those of
Ito and IK,slow1,
did not have an appreciable voltage dependence (Fig. 1C). To
evaluate the steady-state inactivation of
IK,slow2, a standard double-pulse protocol
was applied in the Kv1DN myocytes. Test prepulses of 10 s from
80 to 40 mV were applied to reach a steady state of inactivation, followed by a 10-s depolarization pulse at 40 mV to evoke the current
(Fig. 4C, inset).
IK,slow2 was determined as the difference between the current at 200 ms after depolarization and that at the end
of the pulse. The normalized current values were then plotted against
the test membrane potentials (Fig. 4C) and fitted by a
single Boltzmann function. The averaged half-inactivation voltage
(V'1/2) and the slope factor
(S') from eight observations were
31.0 ± 5.8 and
6.7 ± 2.2 mV, respectively. Fitting the mean data shown in Fig.
5B resulted in a
V'1/2 of
32.0 mV and an S'
of
6.5 mV.
|
70 to 40 mV) of
different intervals were applied, and the currents were measured. The
current elicited by the second pulse was then normalized to that
elicited by the first pulse and is plotted in Fig. 4D. Two
exponentials were needed to describe the recovery kinetics of
IK,slow2 with an initial time constant of
149.0 ± 55.3 ms for ~35% recovery and 2,079.6 ± 946.8 ms
for the remaining IK,slow2 to recover
(n = 5).
Pharmacological profile of IK,slow2. To study the sensitivity of IK,slow2 to the blockade of TEA, cells were superfused with Tyrode solution containing different concentrations of this agent (Fig. 5A). The amplitude of currents, measured as the difference between the level at 200-ms depolarization and that at the end of the pulse, were normalized to the respective control values (before drug application) and plotted as a function of the concentration (Fig. 5B). The concentration-dependent effect was evaluated by fitting the data to the Hill equation. The IC50 of TEA necessary to block IK,slow2 was 638 ± 231 µM (mean ± SE; n = 7), and the nH of 1.0 indicates that TEA binds to a single site of the IK,slow2 channel. These data suggest that IK,slow2 is much more sensitive to TEA than the two major current components of the outward current, Ito and IK,slow1, which are relatively insensitive to TEA (up to 10 mM) (18).
Another potassium channel blocker, 4-AP, also inhibits IK,slow2 (Fig. 5C). The IC50 of 4-AP to block this current was 892 ± 156 µM (mean ± SE; n = 4) with nH of ~1.0 (Fig. 5D). It is noteworthy that both Ito and IK,slow1 are more vulnerable to the blockade of 4-AP than IK,slow2 (IC50 of ~300 and ~30 µM, respectively) (8, 14). In contrast, E-4031 at 2 µM had no significant effect on IK,slow2 (data not shown), indicating that the rapidly activating, delayed rectifying potassium channel (IKr) did not contribute to the IK,slow2. Similarly, this current was not sensitive to 28.6 nM
-dendrotoxin (DTX; data
not shown). At this concentration, DTX effectively inhibited the
Kv1.2-encoded currents (7).
Functional role of IK,slow2.
To evaluate the functional importance of the upregulation of
IK,slow2, we applied 5 mM TEA to control and
Kv1DN myocytes and investigated its effect on their action potentials.
As shown in Fig. 6A, the APD
of a representative Kv1DN cardiac cell was significantly prolonged by
the application of 5 mM TEA, whereas only a mild effect was seen in a
control myocyte. The prolongation was more profound in the late phase
of repolarization. Similar effects were observed in several other Kv1DN
and control myocytes. At this concentration, TEA prolonged the APD at
95% repolarization by 70.4 ± 51.6% (from 61.1 ± 1.1 to
105.0 ± 3.9 ms; n = 7) in Kv1DN cardiocytes and
by 17.4 ± 16.7% (from 48.3 ± 39.4 to 56.2 ± 45.7 ms;
n = 10) in control myocytes (P < 0.01), whereas the prolongation of APD at 30%, 50%, and 70%
repolarization in both groups did not differ significantly (Fig.
6B). The prolongation of the APD by TEA in Kv1DN myocytes
showed a large variation, reflecting the uneven upregulation of the
TEA-sensitive current, IK,slow2, in the
whole ventricle and its different functional contributions in myocytes
that have different lengths of repolarization. These results indicate
that IK,slow2 participates in the last stage
of repolarization in the formation of the action potential, which is
supported by the relatively slow activation kinetics of this current.
Upregulated IK,slow2 contributes more to the repolarization of the action potential in Kv1DN myocytes.
|
IK,slow2 is eliminated by crossbreeding with Kv2DN
mice.
Our data indicate that the biophysical and pharmacological properties
of IK,slow2 are similar to those of the Kv2
family of voltage-gated potassium channels (see
DISCUSSION). To show the correlation between the expression
of the Kv2 gene and this current, we first checked the steady-state
levels of Kv2.1 transcript in either control or Kv1DN hearts. The
results revealed that there was a twofold increase in the steady-state
level of Kv2.1 transcript (Fig.
7A). Real-time PCR also showed
a twofold increase in Kv2.1 transcript (data not shown). To further
determine the gene that codes for the upregulated
IK,slow2, we crossbred Kv1DN mice with mice
expressing a truncated Kv2 polypeptide in the heart (Kv2DN). Kv1/Kv2DN
cardiocytes exhibited outward currents (Fig. 7B) that lacked
both the 4-AP- (Fig. 7E) and the TEA (Fig.
7F)-sensitive components of
IK,slow. Thus overexpression of
Kv2N216 eliminated IK,slow2 in
Kv1DN mice
|
| |
DISCUSSION |
|---|
|
|
|---|
IK,slow2 is encoded by Kv2.1.
Our recent studies (14, 18) suggest that, besides
Ito, a rapidly activating, slowly
inactivating 4-AP-sensitive delayed rectifier current plays an
important role in the cardiac repolarization of murine hearts. This
current, first termed Islow (now referred to
as IK,slow1), has an inactivation constant
of ~400 ms at room temperature. The continued decline of the outward
current of mouse ventricular myocytes after 3-4 s of
depolarization, when IK,slow1 is already
fully inactivated, pointed toward the existence of another component
(IK,slow2) with slower inactivation kinetics than IK,slow1. In the present paper, we have
described the electrophysiological features and functional significance
of IK,slow2. To separate the existing three
components in the total outward current of the control (wild-type)
myocytes, we applied three exponentials to best describe the current
decay. Although the curve-fitting method to determine the number of
current components is relatively crude and may introduce bias, we have
found that the utility of three-exponential fitting in control myocytes
is not only statistically valid (examined by F-test, which
indicated that goodness of fit by 3 exponentials is superior to the
2-exponential model at potentials more positive than 10 mV when all
current components are well activated; Ref. 18) but also
well supported by the functional data: 1) The 4-AP-sensitive
current (IK,slow1) had only one inactivation component with time constants (400-500 ms) similar to
2 obtained from the control outward current, and it was
completely inactivated within 3-4 min, as could be calculated from
2; 2) the TEA-sensitive (at <1 mM) current
(IK,slow2) also had single-exponential
inactivation kinetics with time constants of 1.6-2 s
indistinguishable from
3; 3) in Kv1DN mouse
myocytes, IK,slow1 was selectively
eliminated, leaving Ito and
IK,slow2 with unchanged time constants
compared with
1 and
3 in the control
current. Obviously, the use of two exponentials to fit the current
decay of control myocytes will give different kinetic parameters, and
therefore the time constants of ~80 ms for inactivation of
Ito and >1 s for
"IK,slow" reported by Xu et al.
(17) actually reflect an incomplete separation of
Ito, IK,slow1,
and IK,slow2. In fact, in the studies on
Kv2DN mice (16), these authors described an
"accelerated" inactivation kinetics of
IK,slow, so they suspected that it might
have two components and that the slower component was likely encoded by the Kv2
-subunits. The present study refines and extends these observations and fully characterizes
IK,slow2.
Prolongation of APD and QT interval-induced electrical remodeling.
We created a mouse with a marked reduction in
IK,slow1, a significant prolongation of the
APD, and a prolonged QT interval (14). The mouse heart
exhibited an enhanced spatial dispersion of repolarization and a highly
arrhythmogenic substrate (4, 12). Here we showed that the
suppression of IK,slow1 was associated with
an upregulation of IK,slow2. The gating
properties and pharmacological features of
IK,slow2 in the transgenic mice were not
altered. Therefore, it is likely that the increase of
IK,slow2 was due to either an increase in
the number of the functional channels or an increase of open
probability, although single-channel recordings were not conducted to
rule out the possibility of altered single-channel conductance. Thus
the prolongation of APD and QT interval likely triggered the induction
of IK,slow2 to partially compensate for the
loss of IK,slow1. Interestingly, a similar
electrical remodeling phenomenon was also described in transgenic mice
(Kv4DN) overexpressing Kv4.2W362F (5), a nonconducting
mutant Kv4.2
-subunit, in the heart. The selective suppression of
Ito,f in these mice resulted in the
induction of Ito,s, a slowly inactivating
transient outward current (10). Together, these
observations suggest that the electrical remodeling induced by the
inhibition of a repolarizing current is gene specific and triggers a
compensatory response of a current most similar to the suppressed current.
Limitations of this study. The outward current of mammalian cardiac myocytes is normally composed of several different depolarization-activated ionic current components. At least five repolarization currents (10, 14, 16) have been described in adult murine ventricular myocytes: Ito,f, Ito,s, IK,slow1, IK,slow2, and sustained current (Isus). Although these currents have distinct gating and pharmacological properties, it is still difficult to efficiently separate and accurately assess each component. In the present paper, we have used low concentrations of 4-AP or TEA to investigate IK,slow1 or IK,slow2 because, at these concentrations, the two blockers had little effect on the other current. However, the 4-AP- or TEA-sensitive currents represent only part of the IK,slow1 or IK,slow2 (tested at ~IC50 concentrations). Thus the densities of these currents may have been underestimated in our studies. For the measurement of Ito, a curve fitting to a sum of two exponentials was used to resolve the contamination problems and the current traces were elicited by a short (1-s) depolarization pulse in the presence of 25 µM 4-AP to suppress IK,slow1.
It is well known that divalent cations can shield the membrane surface charge and thus shift the voltage dependence of steady-state activation and inactivation (1). An average of 15- or 7-mV shift in the half-activated or -inactivated voltages, respectively, was observed in our previous study (18) for IK,slow1 by 2 mM cobalt without changes in the slope factors and kinetics. Because of the concern that organic calcium antagonists may affect the Kv1.5-like current IK,slow1 (18), which may complicate the analysis in wild-type mouse myocytes, we continued to use cobalt to block the calcium channel in this study. It is highly possible that cobalt exerts a similar effect on IK,slow2 and, therefore, the voltage dependence of the current gating reported here may have been positively shifted. In a previous optical mapping study examining the action potentials on the epicardial surface of the left ventricle (4), we demonstrated a shorter APD in the apex than in the base. In the present study, we used myocytes isolated from the apex and base of the left ventricles. Apart from an enhanced expression of IK,slow2 in the apical myocytes, we also observed that the densities of this current (and Ito and IK,slow1, as well) varied widely within each group. This variability may represent transmural heterogeneity of the expression of outward potassium currents. Thus the actual regional differences in the whole heart may also have been underestimated by simply comparing apical and basal myocytes.| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Gary F. Mitchell for assistance in the statistical analyses.
| |
FOOTNOTES |
|---|
* J. Zhou and S. Kodirov contributed equally to this work.
This work was supported, in part, by the National Heart, Lung, and Blood Institute (G. Koren and J. Nerbonne). M. Murata was the recipient of a fellowship from the Japanese Heart Foundation.
Present address of J. Zhou: Department of Safety Pharmacology, Pfizer Global Research and Development, Groton, CT 06340.
Address for reprint requests and other correspondence: G. Koren, Cardiovascular Division, Dept. of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 (E-mail: koren{at}calvin.bwh.harvard.edu; http://bioelectricity-lab.bwh.harvard.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/ajpheart.00576.2002
Received 9 July 2002; accepted in final form 7 October 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Agus, ZS,
Dukes ID,
and
Morad M.
Divalent cations modulate the transient outward current in rat ventricular myocytes.
Am J Physiol Cell Physiol
261:
C310-C318,
1991
2.
Antzelevitch, C,
Shimizu W,
Yan G,
Sicouri S,
Weissenburger J,
Nesterenko V,
Burashnikov A,
Diego J,
Saffitz J,
and
Thomas G.
The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart.
J Cardiovasc Electrophysiol
10:
1124-1152,
1999[Web of Science][Medline].
3.
Babij, P,
Askew GR,
Nieuwenhuijsen B,
Su CM,
Bridal TR,
Jow B,
Argentieri TM,
Kulik J,
DeGennaro LJ,
Spinelli W,
and
Colatsky TJ.
Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.
Circ Res
83:
668-678,
1998
4.
Baker, LC,
London B,
Choi BR,
Koren G,
and
Salama G.
Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia.
Circ Res
86:
396-407,
2000
5.
Barry, DM,
Xu H,
Schuessler RB,
and
Nerbonne JM.
Functional knockout of the transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing a dominant-negative Kv4
subunit.
Circ Res
83:
560-567,
1998
6.
Cerbai, E,
Zaza A,
and
Mugelli A.
Pharmacology of membrane ion channels in human myocytes.
In: Cardiac Electrophysiology: From Cell To Bedside (3rd ed.), edited by Jalife J.. Philadelphia, PA: Saunders, 1999, p. 167-173.
7.
Chandy, KG,
and
Gutman GA.
Voltage-gated potassium channel genes.
In: Handbook of Receptors and Channels: Ligand and Voltage-Gated Ion Channels, edited by North RA.. Boca Raton, FL: CRC, 1995, p. 1-71.
8.
Fiset, C,
Clark RB,
Larsen TS,
and
Giles WR.
A rapidly activating sustained K+ current modulates repolarization and excitation-contraction coupling in adult mouse ventricle.
J Physiol
504:
557-563,
1997
9.
Folco, E,
Mathur R,
Mori Y,
Buckett P,
and
Koren G.
A cellular model for long QT syndrome. Trapping of heteromultimeric complexes consisting of truncated Kv11 potassium channel polypeptides and native Kv14 and Kv15 channels in the endoplasmic reticulum.
J Biol Chem
272:
26505-26510,
1997
10.
Guo, W,
Xu H,
London B,
and
Nerbonne JM.
Molecular basis of transient outward K+ current diversity in mouse ventricular myocytes.
J Physiol
521:
587-599,
1999
11.
Hamill, OP,
Marty A,
Neher E,
Sakmann B,
and
Sigworth FJ.
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch
391:
85-100,
1981[Web of Science][Medline].
12.
Jeron, A,
Mitchell GF,
Zhou J,
Murata M,
London B,
Buckett P,
Wiviott S,
and
Koren G.
Inducible polymorphic ventricular tachyarrhythmias in a transgenic mouse model with a long Q-T phenotype.
Am J Physiol Heart Circ Physiol
278:
H1891-H1898,
2000
13.
Kupershmidt, S,
Yang T,
Anderson ME,
Wessels A,
Niswender KD,
Magnuson MA,
and
Roden DM.
Replacement by homologous recombination of the minK gene with lacZ reveals restriction of minK expression to the mouse cardiac conduction system.
Circ Res
84:
146-152,
1999
14.
London, B,
Jeron A,
Zhou J,
Buckett P,
Han X,
Mitchell GF,
and
Koren G.
Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel.
Proc Natl Acad Sci USA
95:
2926-2931,
1998
15.
Roden, DM,
Lazzara R,
Rosen M,
Schwartz PJ,
Towbin J,
and
Vincent GM.
Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.
Circulation
94:
1996-2012,
1996
16.
Xu, H,
Barry DM,
Li H,
Brunet S,
Guo W,
and
Nerbonne JM.
Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2
subunit.
Circ Res
85:
623-633,
1999
17.
Xu, H,
Guo W,
and
Nerbonne JM.
Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes.
J Gen Physiol
113:
661-678,
1999
18.
Zhou, J,
Jeron A,
London B,
Han X,
and
Koren G.
Characterization of a slowly inactivating outward current in adult mouse ventricular myocytes.
Circ Res
83:
806-814,
1998
This article has been cited by other articles:
![]() |
A. L. Taylor, J.-M. Goaillard, and E. Marder How Multiple Conductances Determine Electrophysiological Properties in a Multicompartment Model J. Neurosci., April 29, 2009; 29(17): 5573 - 5586. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Xiao, J. Xiao, X. Luo, H. Lin, Z. Wang, and S. Nattel Feedback Remodeling of Cardiac Potassium Current Expression: A Novel Potential Mechanism for Control of Repolarization Reserve Circulation, September 2, 2008; 118(10): 983 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lu, J.-i. Abe, J. Taunton, Y. Lu, T. Shishido, C. McClain, C. Yan, S. P. Xu, T. M. Spangenberg, and H. Xu Reactive Oxygen Species-Induced Activation of p90 Ribosomal S6 Kinase Prolongs Cardiac Repolarization Through Inhibiting Outward K+ Channel Activity Circ. Res., August 1, 2008; 103(3): 269 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rivard, P. Paradis, M. Nemer, and C. Fiset Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization Cardiovasc Res, April 1, 2008; 78(1): 53 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. S. O'Connell, J. D. Whitesell, and M. M. Tamkun Localization and mobility of the delayed-rectifer K+ channel Kv2.1 in adult cardiomyocytes Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H229 - H237. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko and R. L. Rasmusson Simulations of propagated mouse ventricular action potentials: effects of molecular heterogeneity Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1816 - H1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-L. Wang, G.-X. Wang, S. Yamamoto, L. Ye, H. Baxter, J. R Hume, and D. Duan Molecular mechanisms of regulation of fast-inactivating voltage-dependent transient outward K+ current in mouse heart by cell volume changes J. Physiol., October 15, 2005; 568(2): 423 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Nerbonne and R. S. Kass Molecular Physiology of Cardiac Repolarization Physiol Rev, October 1, 2005; 85(4): 1205 - 1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, S. V. P. Jones, and W. H. Dillmann Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1448 - H1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, M. McLerie, and A. N. Lopatin Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2790 - H2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dun, S. Baba, T. Yagi, and P. A. Boyden Dynamic remodeling of K+ and Ca2+ currents in cells that survived in the epicardial border zone of canine healed infarcted heart Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1046 - H1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Bondarenko, G. P. Szigeti, G. C. L. Bett, S.-J. Kim, and R. L. Rasmusson Computer model of action potential of mouse ventricular myocytes Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1378 - H1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rosati and D. McKinnon Regulation of Ion Channel Expression Circ. Res., April 16, 2004; 94(7): 874 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. X. Liu, J. Zhou, S. Nattel, and G. Koren Single-channel recordings of a rapid delayed rectifier current in adult mouse ventricular myocytes: basic properties and effects of divalent cations J. Physiol., April 15, 2004; 556(2): 401 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kodirov, M. Brunner, J. M. Nerbonne, P. Buckett, G. F. Mitchell, and G. Koren Attenuation of IK,slow1 and IK,slow2 in Kv1/Kv2DN mice prolongs APD and QT intervals but does not suppress spontaneous or inducible arrhythmias Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H368 - H374. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, W. Guo, K. A. Yamada, and J. M. Nerbonne Selective elimination of IK,slow1 in mouse ventricular myocytes expressing a dominant negative Kv1.5{alpha} subunit Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H319 - H328. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dun, P. Chandra, P. Danilo Jr., M. R. Rosen, and P. A. Boyden Chronic atrial fibrillation does not further decrease outward currents. It increases them. Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1378 - H1384. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |